Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Levocetirizine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    17 result(s) found for: Levocetirizine. Displaying page 1 of 1.
    EudraCT Number: 2018-003139-31 Sponsor Protocol Number: 38RC18.103 Start Date*: 2018-12-04
    Sponsor Name:CHU GRENOBLE ALPES
    Full Title: Efficacy and safety of levocetirizine alone or in combination with tranexamic acid in the treatment of spontaneous chronic urticaria. Multicentric controlled randomized study in cross-over, double-...
    Medical condition: Chronique Spontaneous urticaria
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-000358-65 Sponsor Protocol Number: A00394 Start Date*: 2005-11-21
    Sponsor Name:UCB Pharma S.A.
    Full Title: A multicentre, double-blind, two parallel groups, randomized trial over four weeks of treatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the mo...
    Medical condition: Chronic Idiopathic Urticaria
    Disease: Version SOC Term Classification Code Term Level
    8.0 10009159 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) ES (Completed) IT (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005608-15 Sponsor Protocol Number: Levo-6-06 Start Date*: 2007-02-12
    Sponsor Name:Institut für Atemwegsforschung GmbH
    Full Title: Efficacy of Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Rhinitis
    Medical condition: Perennial allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10034382 Perennial allergic rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-006379-19 Sponsor Protocol Number: IGG-GIRO-001 Start Date*: 2007-05-08
    Sponsor Name:ISTITUTO GIANNINA GASLINI
    Full Title: Evaluation of a treatment with levocetirizine in children allergic to mites suffering for recurrent respiratory infections with or without concomitant asthma symptoms
    Medical condition: persistent allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039085 Rhinitis allergic LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-003858-26 Sponsor Protocol Number: A00392 Start Date*: 2005-03-02
    Sponsor Name:UCB PHARMA
    Full Title: A pilot, open, monocenter, randomized two parallel groups, clinical efficacy trial: Comparison continuous versus on demand regimen of treatment with Levocetirizine 5 mg oral tablets, once a day, in...
    Medical condition: Respiratory Allergy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-001245-33 Sponsor Protocol Number: BILA 2006/UCI Start Date*: 2006-07-31
    Sponsor Name:FAES FARMA S.A.
    Full Title: “Estudio en fase III, doble ciego, randomizado, controlado con placebo, comparativo de la eficacia y seguridad de bilastina 20 mg una vez al día y levocetirizina 5 mg para el tratamiento de la ...
    Medical condition: Chronic Idiopathic Urticaria
    Disease: Version SOC Term Classification Code Term Level
    8.1 10021247 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DE (Completed) BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000683-27 Sponsor Protocol Number: GRAY09 Start Date*: 2006-05-17
    Sponsor Name:Research and Innovation Services
    Full Title: A Placebo Controlled Trial to Evaluate The Effects of Levocetirizine on Nasal Allergen Challenge And Adenosine Monophosphate Challenge In Patients with Intermittent and Persistent Allergic Rhinitis
    Medical condition: Allergic Rhinitis - Both Persistent and Intermittent
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-001457-16 Sponsor Protocol Number: RINKAST Start Date*: 2005-09-06
    Sponsor Name:UNIVERSITA' DEGLI STUDI DI UDINE
    Full Title: RANDOMIZED, DOUBLE BLIND TRIAL MONTELUKAST VERSUS LEVOCETIRIZINE IN THE TREATMENT OF SEASONAL RHINITIS AND CONJUNCTIVITIS IN CHILDREN 6-14 YEARS OLD
    Medical condition: TREATMENT OF ALLERGIC SEASONAL RHINITIS AND ALLERGIC SEASONAL CONJUCTIVITIS
    Disease: Version SOC Term Classification Code Term Level
    6.1 10039095 PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003458-28 Sponsor Protocol Number: A00423 Start Date*: 2015-02-18
    Sponsor Name:UCB, Inc.
    Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months With...
    Medical condition: Allergic Rhinitis Chronic Urticaria
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004870 10001738 Allergy LLT
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2015-000205-39 Sponsor Protocol Number: A00426 Start Date*: 2015-02-18
    Sponsor Name:UCB, Inc.
    Full Title: A Multi-Center, Randomized, Double Blind, Placebo Controlled Parallel Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation b.i.d Dosing in Children Aged 1 to < 6 Year...
    Medical condition: Allergic Rhinitis Chronic Urticaria
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004870 10001738 Allergy LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2004-002823-42 Sponsor Protocol Number: A00401 Start Date*: 2005-05-02
    Sponsor Name:UCB S.A. Pharma Sector
    Full Title: A multicentre, double-blind, parallel, randomized, placebo-controlled study : Evaluation of the efficacy and safety of Levocetirizine 5 mg and Desloratadine 5 mg administered orally as capsules onc...
    Medical condition: Allergic Rhinitis (AR)
    Disease: Version SOC Term Classification Code Term Level
    7.1 10001723 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-015381-64 Sponsor Protocol Number: CRI-2009-09-001-IV Start Date*: 2009-11-16
    Sponsor Name:Clinical Research International Ltd.
    Full Title: "3D-Visualization of the anti-obstructive effect of Levocetirizine"
    Medical condition: patient with seasonal allergic rhinitis caused by pollen-allergens
    Disease: Version SOC Term Classification Code Term Level
    12.0 10001726 Allergic rhinitis due to pollen LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002971-18 Sponsor Protocol Number: A00391 Start Date*: 2005-04-29
    Sponsor Name:UCB S.A. Pharma Sector
    Full Title: A monocenter, double-blind, randomized trial, with two parallel groups comparing the clinical efficacy of levocetirizine 5 mg capsules and desloratadine 5 mg capsules taken once a day over 3 weeks ...
    Medical condition: Adult subjects suffering from seasonal allergic rhinitis (SAR) due to grass pollen
    Disease: Version SOC Term Classification Code Term Level
    7.1 10039776 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-003572-19 Sponsor Protocol Number: V00114 CP 302 2A Start Date*: 2007-12-04
    Sponsor Name:Pierre Fabre Médicament
    Full Title: EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIV...
    Medical condition: The intended indication for the product under development is the treatment of perennial allergic rhinitis.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: EE (Prematurely Ended) LT (Prematurely Ended) CZ (Completed) GB (Prematurely Ended) ES (Completed) FI (Prematurely Ended) LV (Completed) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-008734-36 Sponsor Protocol Number: V00114CP3052A Start Date*: 2009-04-14
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: ESTUDIO DE LA EFICACIA Y SEGURIDAD DEL ANTIHISTAMÍNICO V0114CP 2,5 MG EN EL TRATAMIENTO DE LA RINITIS ALÉRGICA ESTACIONAL. ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE TRES RAMAS Y GRUPOS PARALELOS, QU...
    Medical condition: Rinitis alérgica
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended) LT (Prematurely Ended) DE (Prematurely Ended) PL (Completed) SK (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended) BE (Completed)
    Trial results: View results
    EudraCT Number: 2012-001591-11 Sponsor Protocol Number: 3.4.11.049 Start Date*: 2012-12-21
    Sponsor Name:Erasmus MC
    Full Title: Symptomatic treatment of pollen related allergic rhinoconjunctivitis and the relation with asthma with children in the General practice
    Medical condition: Allergic Rhinitis Asthma
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002231-27 Sponsor Protocol Number: LOB-LEV-2005-02 Start Date*: 2006-01-16
    Sponsor Name:Clínica del Dr. Lobatón
    Full Title: Estudio prospectivo, in vivo, aleatorizado, controlado, abierto, de fase IV, en grupos paralelos para medir el efecto de los antihistamínicos (levocetirizina 5 mg/día y ebastina 20 mg/día, vía oral...
    Medical condition: Rinitis alérgica estacional
    Disease: Version SOC Term Classification Code Term Level
    7.1 10039776 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 14:48:36 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA